PLAY PODCASTS
[HEALTH INTEL CANADA TEASER] 🇨🇦 PMPRB Staff Guidelines for Patented Medicine Price Reviews
Season 1 · Episode 49

[HEALTH INTEL CANADA TEASER] 🇨🇦 PMPRB Staff Guidelines for Patented Medicine Price Reviews

AI Unraveled: The Daily Pulse (2-Minute Briefings) · Etienne Noumen

March 24, 20261m 17s

Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Access ADS-FREE Full Audio Briefing at our DjamgaMind Feed at https://djamgamind.com

Summary: This DjamgaMind Special performs a macroeconomic autopsy on Canada’s newly activated "Guidelines for PMPRB Staff." We move past the political talking points to identify the fatal flaw of the PMPRB11 basket: the "Global Referencing Contagion." This episode explores the new Two-Step Review Process, the danger of the Therapeutic Class Comparison (TCC), and why international biotech firms are actively choosing to cancel the launch of life-saving orphan drugs in Canada to protect their global pricing models.

Key Intelligence Covered:

  • The Two-Step Process: A technical breakdown of the Initial/Annual screening and the rigorous In-Depth Review.
  • The PMPRB11 Squeeze: How the removal of the US and Switzerland artificially lowers the Highest International Price (HIP) threshold.
  • Global Referencing Contagion: The forensic math of why launching a drug at a heavy discount in Canada destroys a pharmaceutical company's global revenue.
  • The Galderma Effect: How recent legal pushback stripped the PMPRB of its "clinical similarity" jurisdiction, and how the board is adjusting its tactics.
  • The "Launch Delay" Crisis: Why Canada has become a "Tier 3" launch market, leaving Canadian patients waiting years for breakthrough treatments.

Strategic Signal: Local Price Controls as a Global Launch Deterrent.

Keywords: PMPRB 2026 Guidelines, Patented Medicine Prices Review Board, PMPRB11, Highest International Price (HIP), Two-Step Review Process, Global Referencing Contagion, Drug Pricing Canada, Therapeutic Class Comparison (TCC), Galderma Decision, Health Canada Regulation, DjamgaMind, Etienne Noumen, Regulatory Forensics.

🎙️ DjamgaMind: Tired of the ads? Get the forensic version of this news. Join our Ads-FREE Premium Feed at DjamgaMind. Technical, deep, and uninterrupted. 👉 Switch to Ads-Free: DjamgaMind on Apple Podcasts

Contact us [email protected]

Connect with Etienne Noumen: https://www.linkedin.com/in/enoumen/

Partner with us: https://djamgamind.com/partners

⚗️ PRODUCTION NOTE: We Practice What We Preach.

AI Unraveled is produced using a hybrid "Human-in-the-Loop" workflow. While all research, interviews, and strategic insights are curated by Etienne Noumen, we leverage advanced AI voice synthesis for our daily narration to ensure speed, consistency, and scale.